
|Articles|November 2, 2002
- Pharmaceutical Technology-11-02-2002
- Volume 26
- Issue 11
Major Changes Ahead for FDA
Author(s)Jill Wechsler
FDA is juggling momentous changes, including new leadership and the proposed transfer of oversight for therapeutic biotech drugs.
Advertisement
Articles in this issue
over 23 years ago
Contract Servicesover 23 years ago
Residual Solvent Analysis in PharmaceuticalsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
Women in STEM: Early Phase Drug Development
4
PharmTech Weekly Roundup - February 6, 2026
5




